Inovio Pharmaceuticals Statistics
Total Valuation
BMV:INO has a market cap or net worth of MXN 2.59 billion. The enterprise value is 1.85 billion.
| Market Cap | 2.59B |
| Enterprise Value | 1.85B |
Important Dates
The last earnings date was Monday, November 10, 2025.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 68.70M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +53.38% |
| Shares Change (QoQ) | +34.35% |
| Owned by Insiders (%) | 0.42% |
| Owned by Institutions (%) | 30.17% |
| Float | 68.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 773.67 |
| PB Ratio | -18.27 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.93 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.13 |
Financial Position
The company has a current ratio of 0.79
| Current Ratio | 0.79 |
| Quick Ratio | 0.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.11 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -328.45% and return on invested capital (ROIC) is -127.02%.
| Return on Equity (ROE) | -328.45% |
| Return on Assets (ROA) | -63.56% |
| Return on Invested Capital (ROIC) | -127.02% |
| Return on Capital Employed (ROCE) | 20,471.67% |
| Revenue Per Employee | 24,959 |
| Profits Per Employee | -14.80M |
| Employee Count | 134 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.11% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -61.11% |
| 50-Day Moving Average | 42.10 |
| 200-Day Moving Average | 98.70 |
| Relative Strength Index (RSI) | 35.19 |
| Average Volume (20 Days) | 98 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.92 |
Income Statement
In the last 12 months, BMV:INO had revenue of MXN 3.34 million and -1.98 billion in losses. Loss per share was -51.00.
| Revenue | 3.34M |
| Gross Profit | -1.04B |
| Operating Income | -1.65B |
| Pretax Income | -1.98B |
| Net Income | -1.98B |
| EBITDA | -1.62B |
| EBIT | -1.65B |
| Loss Per Share | -51.00 |
Balance Sheet
The company has 931.84 million in cash and 183.79 million in debt, giving a net cash position of 748.05 million.
| Cash & Cash Equivalents | 931.84M |
| Total Debt | 183.79M |
| Net Cash | 748.05M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -141.60M |
| Book Value Per Share | -2.64 |
| Working Capital | -268.60M |
Cash Flow
In the last 12 months, operating cash flow was -1.63 billion and capital expenditures -2.90 million, giving a free cash flow of -1.63 billion.
| Operating Cash Flow | -1.63B |
| Capital Expenditures | -2.90M |
| Free Cash Flow | -1.63B |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -49,202.88% |
| Pretax Margin | -59,281.69% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BMV:INO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -53.38% |
| Shareholder Yield | -53.38% |
| Earnings Yield | -76.62% |
| FCF Yield | -63.15% |
Stock Splits
The last stock split was on January 25, 2024. It was a reverse split with a ratio of 0.0833333333.
| Last Split Date | Jan 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0833333333 |
Scores
BMV:INO has an Altman Z-Score of -40.51 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -40.51 |
| Piotroski F-Score | 3 |